This brief provides a new explanation for why healthcare cost growth is showing restraint. Specifically, we find evidence that the healthcare sector is finally managing…
No Press items were found.
Insurers and politicians have been complaining that Solvadi—Gilead’s new cure for hepatitis C—costs too much at $84,000 per treatment. But that complaint, while accurately reflecting…
I’ve been critical of the FDA in the past. But now that the FDA has released its long-awaited guidance for “Mobile Medical Applications,” I’m pleasantly…
In a fairly predictable development, the Republican Party and the conservative movement are showing some signs of division over strategy and tactics, if not much…
No Events were found.
1101 14th Street, NW, Suite 1250
Washington, DC 20005
© 2014 Progressive Policy Institute. All rights reserved.